David A. Bristol
Director/Miembro de la Junta en HCF Enterprises, Inc. .
Cargos activos de David A. Bristol
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HCF Enterprises, Inc. | Director/Miembro de la Junta | - | - |
| Sentinel Private Equity XVI Fund | Director/Miembro de la Junta | - | - |
Historial de carrera de David A. Bristol
Antiguos cargos conocidos de David A. Bristol.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Exxon Co. USA | Corporate Officer/Principal | 02/01/1991 | 02/01/1991 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Director/Miembro de la Junta | 28/07/2011 | - |
Formación de David A. Bristol.
| Brown University | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
| HCF Enterprises, Inc. | |
| Exxon Co. USA | |
| Sentinel Private Equity XVI Fund |
- Bolsa de valores
- Insiders
- David A. Bristol
- Experiencia
